Publication | Closed Access

Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup

Pharmacokinetic ModelingPharmacotherapyRurioctacog Alfa PegolPopulation-pharmacokinetic ModelMedicinePhysiologically-based Pharmacokinetic ModelingPharmacokineticsPharmacodynamic Modeling